Back to results
US 5,858,359 AGranted
Antibodies for and treatment to prevent or reduce the severity of xenograft rejection
OwnerHerve Bazininventor
Life of this patent
Estimating the term…
Abstract
Anti-human IgM antibody; in particular, an anti-human mu chain antibody can be employed for reducing patient levels of natural antibodies which are xenoreactive to eliminate or reduce the severity of xenograft rejection.
Claims5
A method of treatment against xenograft rejection in a human patient comprising the step of:
- contacting in vivo the blood of said human patient with at least one antibody which specifically binds to human IgM in an amount effective for reducing blood levels of natural antibodies that are xenoreactive.
Dependencies are inferred from the claim text.